SYGGF (Synairgen) Beginning Cash Position: $10.88 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Synairgen Beginning Cash Position?

Synairgen SYGGF Beginning Cash Position is $10.88 Mil as of Dec. 2024.

Synairgen's Beginning Cash Position for the quarter that ended in Dec. 2024 was $10.88 Mil.

Synairgen's quarterly Beginning Cash Position declined from Dec. 2023 ($13.46 Mil) to Jun. 2024 ($13.38 Mil) and declined from Jun. 2024 ($13.38 Mil) to Dec. 2024 ($10.88 Mil).

Synairgen's annual Beginning Cash Position declined from Dec. 2022 ($41.20 Mil) to Dec. 2023 ($20.16 Mil) and declined from Dec. 2023 ($20.16 Mil) to Dec. 2024 ($13.30 Mil).

Synairgen Beginning Cash Position Related Terms

Synairgen Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Synairgen's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synairgen Beginning Cash Position Chart

Synairgen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.30 99.70 41.20 20.16 13.30

Synairgen Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.95 20.11 13.46 13.38 10.88

Synairgen Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $10.88 Mil mean?
Synairgen (SYGGF) has a Beginning Cash Position of $10.88 Mil as of Dec. 2024. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Synairgen and its competitors.
Is Synairgen's Beginning Cash Position too high?
Synairgen's current Beginning Cash Position is $10.88 Mil.
How does Synairgen's Beginning Cash Position compare to RGBP and CNBX?
Synairgen's Beginning Cash Position of $10.88 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Synairgen and its competitors. Synairgen's current Beginning Cash Position is $10.88 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synairgen stock overvalued right now?
Synairgen (SYGGF) has a current Beginning Cash Position of $10.88 Mil. The current Beginning Cash Position is $10.88 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Synairgen (SYGGF), the current Beginning Cash Position is $10.88 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Synairgen Business Description

Address Southampton General Hospital, Tremona Road, Mailpoint 810, Level F, South Block, Southampton, GBR, SO16 6YD
Synairgen PLC is a United Kingdom-based respiratory drug discovery and development company. The company is engaged in the drug discovery and development of therapies for respiratory diseases, particularly in areas including severe asthma, kidney fibrosis, cardiac fibrosis, chronic obstructive pulmonary disease, and idiopathic pulmonary fibrosis. The company's Programmes include SNG001, SG016, SG018, and others.